Daiwa Securities Group Inc. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$20.0%2150.0%0.00%
Q2 2023$20.0%2150.0%0.00%
Q1 2023$20.0%2150.0%0.00%
Q4 2022$2
-99.9%
2150.0%0.00%
Q3 2022$2,0000.0%2150.0%0.00%
Q2 2022$2,0000.0%2150.0%0.00%
Q1 2022$2,0000.0%2150.0%0.00%
Q4 2021$2,000
+100.0%
215
+79.2%
0.00%
Q3 2021$1,000
-50.0%
1200.0%0.00%
Q2 2021$2,0000.0%1200.0%0.00%
Q1 2021$2,0000.0%1200.0%0.00%
Q4 2020$2,000
-60.0%
120
-65.5%
0.00%
Q3 2020$5,000
-84.4%
3480.0%0.00%
-100.0%
Q2 2020$32,000
+300.0%
3480.0%0.00%
Q1 2020$8,000
+14.3%
348
+8.8%
0.00%
Q4 2019$7,0000.0%320
-9.3%
0.00%
Q3 2019$7,000
+16.7%
3530.0%0.00%
Q2 2019$6,000
-25.0%
3530.0%0.00%
Q1 2019$8,000
-20.0%
353
+18.1%
0.00%
Q3 2018$10,000
+42.9%
2990.0%0.00%
Q2 2018$7,0000.0%2990.0%0.00%
Q1 2018$7,0002990.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 10,898,879$264,297,00023.51%
Foundation Asset Management, LP 399,537$9,689,0003.59%
Cormorant Asset Management, LP 1,300,000$31,525,0002.35%
Baupost Group 9,309,168$225,747,0002.18%
Old West Investment Management, LLC 109,320$2,651,0001.53%
SENZAR ASSET MANAGEMENT, LLC 187,856$4,555,0001.44%
Chescapmanager LLC 350,631$8,503,0001.27%
Virtus ETF Advisers LLC 32,989$800,0000.69%
Rock Springs Capital Management LP 652,600$15,826,0000.68%
NJ State Employees Deferred Compensation Plan 34,142$828,0000.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders